spacer
home > epc > spring 2009 > competing with big pharma
PUBLICATIONS
European Pharmaceutical Contractor

Competing with Big Pharma

Good ideas for new drugs can come from anywhere. There was a time – now it seems like ancient history – when virtually all ideas came from the R&D departments of large pharmaceutical companies. Today, they often come from research carried out by dedicated groups of scientists at universities and small and medium-sized biotech firms, or even ‘virtual’ research groups connected by the internet.

Regardless of how it’s achieved, coming up with a concept for a new drug is not a random event. It starts with deciding what questions to ask in order to identify potential targets for a disease, and later focuses on developing strategies to find effective candidates that selectively affect those targets. Through hard work and trial and error, thousands of labs across the UK are developing new candidates every day. Thankfully, with some regularity, one scientist will turn to his or her colleagues and say, “I think we’ve got something here.” Then what?


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer

Mark Crane joined Ricerca as Vice President, Business Development and Marketing in June 2007. Mark has overseen the development of the new Ricerca ‘IP to IND’ brand, as well as the development of the website and sales literature. Prior to joining Ricerca, Mark served as Vice President, Sales and Marketing, for both Bridge Global Pharmaceutical Services and Quest Pharmaceutical Services. Mark was also a Vice President, of Global Business Development, Preclinical/Discovery Services for MDS Pharmaceutical Services, and held various posts at MDS Panlabs, AVANTEC, Inc and the Perkin Elmer Corporation. He holds a BS degree in Health Education/Community Health from Western Connecticut State University at Danbury.

spacer
Mark Crane
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Entry now open for the PPMA Group Industry Awards 2019

The 2019 PPMA Group Industry Awards will be held at the National Conference Centre (NEC), Birmingham, on the evening of the first day of the PPMA Total Show 2019 – Tuesday, 1 October 2019. 
More info >>

White Papers

Quality By Design

Biopharma Group

Quality by Design (QbD) is a systematic approach to development that begins with the defined objectives and emphasizes science and quality risk management in order to achieve those goals. QbD ensures that the quality of the product is built into production processes from the outset, rather than being tested after development has already commenced.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement